高分子バイオマテリアルの市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2024年～2030年

高分子バイオマテリアル市場の成長と動向：

Grand View Research社の最新レポートによると、世界の高分子バイオマテリアルの市場規模は、2030年までに1,488億7,000万米ドルに達すると予測されています。

同市場は2024年から2030年にかけてCAGR 16.54％で拡大すると予測されています。この成長の背景には、製品イノベーションの高まり、組織工学における高分子バイオマテリアルの用途拡大、外科手術における高分子バイオマテリアルのニーズの高まりがあります。

再生医療分野における高分子バイオマテリアルの需要増加が市場成長の原動力となっています。さらに、ポリ乳酸-グリコール酸（PLGA）、ポリエチレングリコール（PEG）、ポリカプロラクトン（PCL）などの合成ポリマーは、細胞送達用途に広く利用されています。同様に、無機構造体を組み込んだ複合ハイドロゲルも、組織修復を目的とした低侵襲的細胞導入の可能性について研究されてきました。

COVID-19パンデミックは、いくつかの封鎖厳格化、サプライチェーン業務の支障、臨床研究活動の減少のため、市場に悪影響を及ぼしました。悪影響にもかかわらず、COVID-19治療のための新たな治療戦略を考案するための高分子バイオマテリアルの採用が増加しているため、市場は長期的に力強い成長見通しを遂げるすると予想されます。例えば、2021年4月にEmergent Materials Journalに掲載された論文によると、COVID-19治療のためにインターロイキン6（IL-6）阻害剤などのドラッグデリバリーを制御するためのバイオマテリアル物質が研究されました。その結果、COVID-19の新規治療薬に対する需要の増加に伴い、市場は今後数年間で大きな成長が見込まれます。

さらに、業界の主要企業は、市場での地位を強化し、顧客基盤を拡大するために、買収、提携、パートナーシップ、事業拡大、新製品の発売など、さまざまな戦略を採用しています。例えば、2023年1月、MicroPort Scientific CorporationはロシアでFirehawk Liberty Rapamycin標的溶出冠動脈ステントシステムの販売承認を取得しました。この承認により、同社の地理的プレゼンスが拡大することが期待されます。さらに、2022年7月、CorbionはSTENTiTおよびVivoltaと、重症四肢虚血患者の臨床使用および治療のための再生ステントの開発で提携しました。このような大手企業による戦略採用の増加は、2023年から2030年までの市場成長を促進すると予想されます。

高分子バイオマテリアルは、他のバイオマテリアル物質と比べて機械的強度と安定性に欠けます。そのため、高い強度や耐久性、耐荷重性を必要とする用途では、用途が限定される可能性があります。しかし、主要プレーヤーによる高分子バイオマテリアルの技術的進歩への投資が増加しているため、予測期間中はこの課題が軽減されると予想されます。

高分子バイオマテリアル市場のレポートハイライト

• 製品別では、ポリ乳酸（PLA）セグメントが2023年に20.85%の最大市場シェアを占めました。このセグメントの成長は、ドラッグデリバリー、インプラントと縫合糸の製造、組織工学アプリケーションの分野で数種類のPLAブレンドが幅広く応用されていることに起因しています。
• 用途別では、整形外科分野が2023年に23.49%のシェアで市場を独占しました。このセグメントの成長は、整形外科疾患の罹患率が増加していることに起因しており、その結果、高分子バイオマテリアルを使用した新規かつより効果的な治療法の発見を科学者たちに促しています。
• 北米は2023年に38.49%の最大市場シェアを占めましたが、これは整形外科的損傷や美容整形手術の手術件数の増加と持続可能なバイオマテリアルの必要性によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 付随市場の見通し
• 市場動向と展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 事業環境分析
  • PESTEL分析
  • ポーターのファイブフォース分析
• COVID-19の影響分析

第4章 製品ビジネス分析

• 高分子バイオマテリアル市場：製品変動分析
• ポリ乳酸（PLA）
  • 世界のポリ乳酸
• ポリグリコール酸（PGA）
  • 世界のポリグリコール酸
• ポリウレタン
  • 世界のポリウレタン市場、2018年～2030年
• ポリテトラフルオロエチレン（PTFE）および延伸ポリテトラフルオロエチレン（ePTFE）
  • 世界のポリテトラフルオロエチレン
• ポリアリールエーテルエーテルケトン（PEEK）
  • 世界のポリアリルエーテルエーテルケトン
• ポリジオキサノン（Pdo）
  • 世界のポリジオキサノン
• その他
  • 世界のその他製品市場、2018年～2030年

第5章 アプリケーションビジネス分析

• 高分子バイオマテリアル市場：アプリケーション変動分析
• 心臓血管
  • 世界の心臓血管市場、2018年～2030年
  • 生体吸収性ステント
  • 血管移植片
  • センサー
  • ガイドワイヤー
  • 植込み型除細動器
  • ペースメーカー
  • その他
• 歯科
  • 世界の歯科市場、2018年～2030年
  • 組織再生材料
  • 歯科インプラント
  • 骨移植片と代用骨
  • 歯の膜
  • 歯科用縫合糸
  • その他
• 形成外科
  • 世界の形成外科市場、2018年～2030年
  • 顔のしわ治療
  • 軟組織充填材
  • 頭蓋顔面外科
  • バイオエンジニアリングスキン
  • 末梢神経の修復
  • 無細胞真皮マトリックス
  • その他
• 神経内科
  • 世界の神経学市場、2018年～2030年
  • 神経幹細胞のカプセル化
  • シャントシステム
  • ヒドロゲル足場
  • 皮質神経補綴物
  • その他
• 整形外科
  • 世界の整形外科市場、2018年～2030年
  • 関節置換高分子バイオマテリアル
  • 組織固定製品
  • オーソバイオロジクス
  • 関節内補充療法
  • 脊椎バイオマテリアル
  • その他
• その他の用途
  • 世界のその他のアプリケーション市場、2018年～2030年

第6章 地域ビジネス分析

• 北米
  • 北米の高分子バイオマテリアル市場推計・予測、2018年～2030年
  • 米国
  • カナダ
• 欧州
  • 欧州の高分子バイオマテリアル市場推計・予測、2018年～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋地域の高分子バイオマテリアル市場推計・予測、2018年～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの高分子バイオマテリアル市場推計・予測、2018年～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカの高分子バイオマテリアル市場推計・予測、2018年～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 参入企業の概要
  • MEDTRONIC
  • STRYKER CORPORATION
  • BASF SE
  • EVONIK INDUSTRIES AG
  • DSM
  • BEZWADA BIOMEDICAL, LLC
  • CORBION
  • VICTREX PLC（INVIBIO LTD.）
  • INTERNATIONAL POLYMER ENGINEERING
  • COVALON TECHNOLOGIES LTD.
  • ABBOTT
  • ELIXIR MEDICAL
  • REVA MEDICAL, LLC
  • MERIL LIFE SCIENCES PVT. LTD.
  • MICROPORT SCIENTIFIC CORPORATION
• 参入企業
  • 高分子バイオマテリアル市場シェア分析、2023年
• 戦略マッピング
  • 拡大
  • 取得
  • コラボレーションとパートナーシップ
  • 製品の発売
  • その他

第8章 アナリストの視点

List of Tables

• Table 1 List of Abbreviations
• Table 2 Global polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 3 Global polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 4 Global polymeric biomaterials market, by region, 2018 - 2030 (USD Million)
• Table 5 North America polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
• Table 6 North America polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 7 North America polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 8 U.S. polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 9 U.S. polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 10 Canada polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 11 Canada polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 12 Europe polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
• Table 13 Europe polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 14 Europe polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 15 Germany polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 16 Germany polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 17 UK polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 18 UK polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 19 France polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 20 France polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 21 Italy polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 22 Italy polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 23 Spain polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 24 Spain polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 25 Denmark polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 26 Denmark polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 27 Sweden polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 28 Sweden polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 29 Norway polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 30 Norway polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 31 Asia Pacific polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
• Table 32 Asia Pacific polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 34 China polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 35 China polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 36 Japan polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 37 Japan polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 38 India polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 39 India polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 40 South Korea polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 41 South Korea polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 42 Australia polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 43 Australia polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 44 Thailand polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 45 Thailand polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 46 Latin America polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
• Table 47 Latin America polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 48 Latin America polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 49 Brazil polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 50 Brazil polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 51 Mexico polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 52 Mexico polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 53 Argentina polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 54 Argentina polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 55 Middle East & Africa polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 56 Middle East & Africa polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 57 South Africa polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 58 South Africa polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 59 Saudi Arabia polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 60 Saudi Arabia polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 61 UAE polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 62 UAE polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
• Table 63 Kuwait polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
• Table 64 Kuwait polymeric biomaterials market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Polymeric biomaterials market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research application
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modeling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market snapshot
• Fig. 13 Segment snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 Biomaterials market value, 2023 (USD Billion)
• Fig. 16 Market trends & outlook
• Fig. 17 PESTEL analysis
• Fig. 18 Porter's five forces analysis
• Fig. 19 Polymeric biomaterials market: Product outlook key takeaways
• Fig. 20 Polymeric biomaterials market: Product movement analysis
• Fig. 21 Global Polylactic Acid (PLA) market, 2018 - 2030 (USD Million)
• Fig. 22 Global Polyglycolic Acid (PGA) market, 2018 - 2030 (USD Million)
• Fig. 23 Global polyurethanes market, 2018 - 2030 (USD Million)
• Fig. 24 Global Polytetrafluoroethylene (PTFE) & expanded Polytetrafluoroethylene (ePTFE) market, 2018 - 2030 (USD Million)
• Fig. 25 Global Polyaryletheretherketone (PEEK) market, 2018 - 2030 (USD Million)
• Fig. 26 Global Polydioxanone (PDO) market, 2018 - 2030 (USD Million)
• Fig. 27 Global other products market, 2018 - 2030 (USD Million)
• Fig. 28 Polymeric biomaterials market: Application outlook and key takeaways
• Fig. 29 Polymeric biomaterials market: Application movement analysis
• Fig. 30 Global cardiovascular market, 2018 - 2030 (USD Million)
• Fig. 31 Global bioresorbable stents market, 2018 - 2030 (USD Million)
• Fig. 32 Global vascular grafts market, 2018 - 2030 (USD Million)
• Fig. 33 Global sensors market, 2018 - 2030 (USD Million)
• Fig. 34 Global guidewires market, 2018 - 2030 (USD Million)
• Fig. 35 Global implantable cardiac defibrillators market, 2018 - 2030 (USD Million)
• Fig. 36 Global pacemakers market, 2018 - 2030 (USD Million)
• Fig. 37 Global others market, 2018 - 2030 (USD Million)
• Fig. 38 Global dental market, 2018 - 2030 (USD Million)
• Fig. 39 Global tissue regeneration market, 2018 - 2030 (USD Million)
• Fig. 40 Global dental implants market, 2018 - 2030 (USD Million)
• Fig. 41 Global bone graft & substitutes market, 2018 - 2030 (USD Million)
• Fig. 42 Global dental membranes market, 2018 - 2030 (USD Million)
• Fig. 43 Global dental sutures market, 2018 - 2030 (USD Million)
• Fig. 44 Global others market, 2018 - 2030 (USD Million)
• Fig. 45 Global plastic surgery market, 2018 - 2030 (USD Million)
• Fig. 46 Global facial wrinkle treatment market, 2018 - 2030 (USD Million)
• Fig. 47 Global soft tissue fillers market, 2018 - 2030 (USD Million)
• Fig. 48 Global craniofacial surgery market, 2018 - 2030 (USD Million)
• Fig. 49 Global sutures market, 2018 - 2030 (USD Million)
• Fig. 50 Global others market, 2018 - 2030 (USD Million)
• Fig. 51 Global bioengineered skins market, 2018 - 2030 (USD Million)
• Fig. 52 Global peripheral nerve repair market, 2018 - 2030 (USD Million)
• Fig. 53 Global acellular dermal matrices market, 2018 - 2030 (USD Million)
• Fig. 54 Global others market, 2018 - 2030 (USD Million)
• Fig. 55 Global neurology market, 2018 - 2030 (USD Million)
• Fig. 56 Global neural stem cell encapsulation market, 2018 - 2030 (USD Million)
• Fig. 57 Global shunting systems market, 2018 - 2030 (USD Million)
• Fig. 58 Global hydrogel scaffold market, 2018 - 2030 (USD Million)
• Fig. 59 Global cortical neural prosthetics, 2018 - 2030 (USD Million)
• Fig. 60 Global others market, 2018 - 2030 (USD Million)
• Fig. 61 Global orthopedic market, 2018 - 2030 (USD Million)
• Fig. 62 Global joint replacement biomaterials market, 2018 - 2030 (USD Million)
• Fig. 63 Global tissue fixation products market, 2018 - 2030 (USD Million)
• Fig. 64 Global sutures market, 2018 - 2030 (USD Million)
• Fig. 65 Global others market, 2018 - 2030 (USD Million)
• Fig. 66 Global orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 67 Global viscosupplementation market, 2018 - 2030 (USD Million)
• Fig. 68 Global spine biomaterials market, 2018 - 2030 (USD Million)
• Fig. 69 Global others market, 2018 - 2030 (USD Million)
• Fig. 70 Global other applications market, 2018 - 2030 (USD Million)
• Fig. 71 Regional marketplace: Key takeaways
• Fig. 72 Regional marketplace: Key takeaways
• Fig. 73 North America polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 U.S. polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 U.S. target disease prevalence
• Fig. 77 Key country dynamics
• Fig. 78 Canada polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Canada target disease prevalence
• Fig. 80 Europe polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 Germany polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Germany. target disease prevalence
• Fig. 84 Key country dynamics
• Fig. 85 UK polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 UK target disease prevalence
• Fig. 87 Key country dynamics
• Fig. 88 France polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 France target disease prevalence
• Fig. 90 Key country dynamics
• Fig. 91 Italy polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Italy target disease prevalence
• Fig. 93 Key country dynamics
• Fig. 94 Spain polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Spain target disease prevalence
• Fig. 96 Key country dynamics
• Fig. 97 Denmark polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Denmark target disease prevalence
• Fig. 99 Key country dynamics
• Fig. 100 Sweden polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 101 Sweden target disease prevalence
• Fig. 102 Key country dynamics
• Fig. 103 Norway polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 104 Norway target disease prevalence
• Fig. 105 Asia Pacific polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 106 Key country dynamics
• Fig. 107 Japan polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 108 Japan target disease prevalence
• Fig. 109 Key country dynamics
• Fig. 110 China polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 111 China target disease prevalence
• Fig. 112 Key country dynamics
• Fig. 113 India polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 114 India target disease prevalence
• Fig. 115 Key country dynamics
• Fig. 116 Australia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 117 Australia target disease prevalence
• Fig. 118 Key country dynamics
• Fig. 119 Thailand polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 120 Key country dynamics
• Fig. 121 South Korea polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 122 South Korea target disease prevalence
• Fig. 123 Latin America polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 124 Key country dynamics
• Fig. 125 Brazil polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 126 Brazil target disease prevalence
• Fig. 127 Key country dynamics
• Fig. 128 Mexico polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 129 Mexico target disease prevalence
• Fig. 130 Key country dynamics
• Fig. 131 Argentina polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 132 Argentina target disease prevalence
• Fig. 133 MEA polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 134 Key country dynamics
• Fig. 135 South Africa polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 136 South Africa target disease prevalence
• Fig. 137 Key country dynamics
• Fig. 138 Saudi Arabia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 139 Saudi Arabia target disease prevalence
• Fig. 140 Key country dynamics
• Fig. 141 UAE polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 142 UAE target disease prevalence
• Fig. 143 Key country dynamics
• Fig. 144 Kuwait polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 145 Kuwait target disease prevalence
• Fig. 146 Market participant categorization
• Fig. 147 Polymeric biomaterials market share analysis, 2023
• Fig. 148 Strategic framework

Polymeric Biomaterials Market Growth & Trends:

The global polymeric biomaterials market size is anticipated to reach USD 148.87 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.54% from 2024 to 2030. The growth is attributed to the rising product innovations, increasing applications of polymeric biomaterials in tissue engineering, and the growing need for polymeric biomaterials in surgical procedures.

Increasing demand for polymeric biomaterials in the field of regenerative medicine is fueling market growth. Polymeric biomaterials such as injectable hydrogels act as a promising solution for the rising demand for minimally invasive cell delivery systems owing to the ability to undergo a flexible sol-gel transition and adaptively fill defects, enabling minimally invasive interventions.Furthermore, several synthetic polymers, such as Poly (lactic-co-glycolic acid) (PLGA), Polyethylene Glycol (PEG), and Polycaprolactone (PCL), are widely utilized in cell delivery applications. Similarly, composite hydrogels incorporating inorganic constructs have also been investigated for their potential in facilitating minimally invasive cell delivery for tissue repair purposes.

The COVID-19 pandemic adversely affected the market in due to several lockdown strictures, hindrances in supply chain operations, and decreased clinical research activities.Despite the negative impact, the market is expected to witness strong growth prospects in the long term due to the increasing adoption of polymeric biomaterials for devising new therapeutic strategies for COVID-19 treatment. For instance, according to an article published in the Emergent Materials Journal in April 2021, biomaterial substances were studied for the controlled delivery of drugs, such as interleukin 6 (IL-6) inhibitors, for COVID-19 treatment. As a result, with the increasing demand for novel therapeutics for COVID-19, the market is expected to witness significant growth in the coming years.

Furthermore, key players in the industry are adopting various strategies such as acquisitions, collaborations, partnerships, expansions and new product launches to strengthen their market position and expand their customer base. For instance, in January 2023, MicroPort Scientific Corporation received marketing approval for its Firehawk Liberty Rapamycin Target Eluting Coronary Stent System in Russia. This approval is anticipated to expand the company's geographical presence. Moreover, in July 2022, Corbion collaborated with STENTiT and Vivolta for the development of a regenerative stent for clinical use and treatment of patients suffering from critical limb ischemia. This increasing adoption of strategies by major companies are anticipated to drive market growth from 2023 to 2030.

Polymeric biomaterials lack mechanical strength and stability as compared to other biomaterial substances. Hence, for applications with high strength, durability, or load-bearing capabilities, it may find limited usage. However, increasing investment in the technological advancement of polymeric biomaterials by major players is anticipated to mitigate this challenge over the forecast period.

Polymeric Biomaterials Market Report Highlights:

• Based on the product, the Polylactic Acid (PLA) segment held the largest market share of 20.85% in 2023. The segment growth is attributed to the wide application of several types of PLA blends in the field of drug delivery, manufacturing of implants & sutures, and tissue engineering applications
• Based on the application, the orthopedic segment dominated the market with a share of 23.49% in 2023. The segment growth is attributed to the growing incidence of orthopedic diseases, which in turn, is encouraging scientists to discover novel and more effective treatment options using polymeric biomaterials
• North America held the largest market share of 38.49% in 2023, owing to a rise in the number of surgical procedures for orthopedic injuries and cosmetic surgeries and the need for sustainable biomaterials

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
• 1.2 Market Definitions
  • 1.2.1 Information Analysis
  • 1.2.2 Market Formulation & Data Visualization
  • 1.2.3 Data Validation & Publishing
• 1.3 Research Assumptions
• 1.4 Information Procurement
  • 1.4.1 Primary Research:
• 1.5 Information or Data Analysis
• 1.6 Market Formulation & Validation
• 1.7 Market Model
• 1.8 Global Market: CAGR Calculation
• 1.9 Objectives

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, and Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Market Trends & Outlook
• 3.3 Market Dynamics
  • 3.3.1 Market Driver Analysis
    • 3.3.1.1 Rising Demand For Polymeric Biomaterials For Minimally Invasive Applications
    • 3.3.1.2 Advancements In Biomaterials Technologies
    • 3.3.1.3 Expansion In The Scope Of Applications For Biomaterials
  • 3.3.2 Market Restraint Analysis
    • 3.3.2.1 High expenses associated with the development and commercialization of biomaterials
    • 3.3.2.2 Problems related to mechanical strength and stability of polymeric biomaterials
• 3.4 Business Environment Analysis
  • 3.4.1 Pestel Analysis
  • 3.4.2 Porter's Five Forces Analysis
• 3.5 COVID-19 Impact Analysis

Chapter 4 Product Business Analysis

• 4.1 Polymeric Biomaterials Market: Product Movement Analysis
• 4.2 Polylactic Acid (PLA)
  • 4.2.1 Global Polylactic Acid (PLA) Market, 2018 - 2030 (USD Million)
• 4.3 Polyglycolic Acid (PGA)
  • 4.3.1 Global Polyglycolic Acid (PGA) Market, 2018 - 2030 (USD Million)
• 4.4 Polyurethanes
  • 4.4.1 Global Polyurethanes Market, 2018 - 2030 (USD Million)
• 4.5 Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • 4.5.1 Global Polytetrafluoroethylene (Ptfe) & Expanded Polytetrafluoroethylene (Eptfe) Market, 2018 - 2030 (USD Million)
• 4.6 Polyaryletheretherketone (PEEK)
  • 4.6.1 Global Polyaryletheretherketone (PEEK) Market, 2018 - 2030 (USD Million)
• 4.7 Polydioxanone (Pdo)
  • 4.7.1 Global Polydioxanone (Pdo) Market, 2018 - 2030 (USD Million)
• 4.8 Others
  • 4.8.1 Global Other Products Market, 2018 - 2030 (USD Million)

Chapter 5 Application Business Analysis

• 5.1 Polymeric Biomaterials Market: Application Movement Analysis
• 5.2 Cardiovascular
  • 5.2.1 Global Cardiovascular Market, 2018 - 2030 (USD Million)
  • 5.2.2 Bioresorbable Stents
    • 5.2.2.1 Global Bioresorbable Stents Market, 2018 - 2030 (USD Million)
  • 5.2.3 Vascular Grafts
    • 5.2.3.1 Global Vascular Grafts Market, 2018 - 2030 (USD Million)
  • 5.2.4 Sensors
    • 5.2.4.1 Global Sensors Market, 2018 - 2030 (USD Million)
  • 5.2.5 Guidewires
    • 5.2.5.1 Global Guidewires Market, 2018 - 2030 (USD Million)
  • 5.2.6 Implantable Cardiac Defibrillators
    • 5.2.6.1 Global Implantable Cardiac Defibrillators Market, 2018 - 2030 (USD Million)
  • 5.2.7 Pacemakers
    • 5.2.7.1 Global Pacemakers Market, 2018 - 2030 (USD Million)
  • 5.2.8 Others
    • 5.2.8.1 Global Others Market, 2018 - 2030 (USD Million)
• 5.3 Dental
  • 5.3.1 Global Dental Market, 2018 - 2030 (USD Million)
  • 5.3.2 Tissue Regeneration Materials
    • 5.3.2.1 Global Tissue Regeneration Market, 2018 - 2030 (USD Million)
  • 5.3.3 Dental Implants
    • 5.3.3.1 Global Dental Implants Market, 2018 - 2030 (USD Million)
  • 5.3.4 Bone Grafts & Substitutes
    • 5.3.4.1 Global Bone Graft & Substitutes Market, 2018 - 2030 (USD Million)
  • 5.3.5 Dental Membranes
    • 5.3.5.1 Global Dental Membranes Market, 2018 - 2030 (USD Million)
  • 5.3.6 Dental Sutures
    • 5.3.6.1 Global Dental Sutures Market, 2018 - 2030 (USD Million)
  • 5.3.7 Others
    • 5.3.7.1 Global others market, 2018 - 2030 (USD Million)
• 5.4 Plastic Surgery
  • 5.4.1 Global Plastic Surgery Market, 2018 - 2030 (USD Million)
  • 5.4.2 Facial Wrinkle Treatment
    • 5.4.2.1 Global Facial Wrinkle Treatment Market, 2018 - 2030 (USD Million)
  • 5.4.3 Soft Tissue Fillers
    • 5.4.3.1 Global Soft Tissue Fillers Market, 2018 - 2030 (USD Million)
  • 5.4.4 Craniofacial Surgery
    • 5.4.4.1 Global Craniofacial Surgery Market, 2018 - 2030 (USD Million)
    • 5.4.4.2 Sutures
    • 5.4.4.2.1 Global Sutures Market, 2018 - 2030 (USD Million)
    • 5.4.4.3 Others
    • 5.4.4.3.1 Others Market, 2018 - 2030 (USD Million)
  • 5.4.5 Bioengineered Skins
    • 5.4.5.1 Global Bioengineered Skins Market, 2018 - 2030 (USD Million)
  • 5.4.6 Peripheral Nerve Repair
    • 5.4.6.1 Global Peripheral Nerve Repair Market, 2018 - 2030 (USD Million)
  • 5.4.7 Acellular Dermal Matrices
    • 5.4.7.1 Global Acellular Dermal Matrices Market, 2018 - 2030 (USD Million)
  • 5.4.8 Others
    • 5.4.8.1 Global others market, 2018 - 2030 (USD Million)
• 5.5 Neurology
  • 5.5.1 Global Neurology Market, 2018 - 2030 (USD Million)
  • 5.5.2 Neural Stem Cell Encapsulation
    • 5.5.2.1 Global Neural Stem Cell Encapsulation Market, 2018 - 2030 (USD Million)
  • 5.5.3 Shunting Systems
    • 5.5.3.1 Global Shunting Systems Market, 2018 - 2030 (USD Million)
  • 5.5.4 Hydrogel Scaffold
    • 5.5.4.1 Global Hydrogel Scaffold Market, 2018 - 2030 (USD Million)
  • 5.5.5 Cortical Neural Prosthetics
    • 5.5.5.1 Global Cortical Neural Prosthetics Market, 2018 - 2030 (USD Million)
  • 5.5.6 Others
    • 5.5.6.1 Global others market, 2018 - 2030 (USD Million)
• 5.6 Orthopedic
  • 5.6.1 Global Orthopedic Market, 2018 - 2030 (USD Million)
  • 5.6.2 Joint Replacement Polymeric Biomaterials
    • 5.6.2.1 Global Joint Replacement Biomaterials Market, 2018 - 2030 (USD Million)
  • 5.6.3 Tissue Fixation Products
    • 5.6.3.1 Global Tissue Fixation Products Market, 2018 - 2030 (USD Million)
    • 5.6.3.2 Sutures
    • 5.6.3.2.1 Global Sutures Market, 2018 - 2030 (USD Million)
    • 5.6.3.3 Other
    • 5.6.3.3.1 Global Other Market, 2018 - 2030 (USD Million)
  • 5.6.4 Orthobiologics
    • 5.6.4.1 Global Orthobiologics Market, 2018 - 2030 (USD Million)
  • 5.6.5 Viscosupplementation
    • 5.6.5.1 Global Viscosupplementation Market, 2018 - 2030 (USD Million)
  • 5.6.6 Spine Biomaterials
    • 5.6.6.1 Global Spine Biomaterials Market, 2018 - 2030 (USD Million)
  • 5.6.7 Others
    • 5.6.7.1 Global others market, 2018 - 2030 (USD Million)
• 5.7 Other Application
  • 5.7.1 Global Other Applications Market, 2018 - 2030 (USD Million)

Chapter 6 Regional Business Analysis

• 6.1 North America
  • 6.1.1 North America Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.1.2 U.S.
    • 6.1.2.1 Key country dynamics
    • 6.1.2.2 U.S. polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.1.2.3 Market scenario
    • 6.1.2.4 Regulatory framework
    • 6.1.2.5 Disease prevalence
  • 6.1.3 Canada
    • 6.1.3.1 Key country dynamics
    • 6.1.3.2 Canada polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.1.3.3 Market scenario
    • 6.1.3.4 Regulatory framework
    • 6.1.3.5 Disease prevelance
• 6.2 Europe
  • 6.2.1 Europe Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2 Germany
    • 6.2.2.1 Key country dynamics
    • 6.2.2.2 Germany polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.2.3 Market scenario
    • 6.2.2.4 Regulatory framework
    • 6.2.2.5 Disease prevelance
  • 6.2.3 UK
    • 6.2.3.1 Key country dynamics
    • 6.2.3.2 UK polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.3.3 Market scenario
    • 6.2.3.4 Regulatory framework
    • 6.2.3.5 Disease Prevelance
  • 6.2.4 France
    • 6.2.4.1 Key Country Dynamics
    • 6.2.4.2 France Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4.3 Market Scenario
    • 6.2.4.4 Regulatory Framework
    • 6.2.4.5 Disease Prevalence
  • 6.2.5 Italy
    • 6.2.5.1 Key country dynamics
    • 6.2.5.2 Italy polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.5.3 Market scenario
    • 6.2.5.4 Regulatory framework
    • 6.2.5.5 Disease prevelance
  • 6.2.6 Spain
    • 6.2.6.1 Key country dynamics
    • 6.2.6.2 Spain polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.6.3 Market scenario
    • 6.2.6.4 Regulatory framework
    • 6.2.6.5 Disease prevelance
  • 6.2.7 Denmark
    • 6.2.7.1 Key Country Dynamics
    • 6.2.7.2 Denmark Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.7.3 Market Scenario
    • 6.2.7.4 Regulatory Framework
    • 6.2.7.5 Disease Prevelance
  • 6.2.8 Sweden
    • 6.2.8.1 Key Country Dynamics
    • 6.2.8.2 Sweden Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.8.3 Market Overview
    • 6.2.8.4 Regulatory Framework
    • 6.2.8.5 Disease Prevelance
  • 6.2.9 Norway
    • 6.2.9.1 Key country dynamics
    • 6.2.9.2 Norway polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.9.3 Market scenario
    • 6.2.9.4 Regulatory framework
    • 6.2.9.5 Disease prevelance
• 6.3 Asia Pacific
  • 6.3.1 Asia Pacific Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2 JAPAN
    • 6.3.2.1 Key country dynamics
    • 6.3.2.2 Japan polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2.3 Market overview
    • 6.3.2.4 Regulatory framework
    • 6.3.2.5 Disease prevelance
  • 6.3.3 China
    • 6.3.3.1 Key Country Dynamics
    • 6.3.3.2 China Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3.3 Market Scenario
    • 6.3.3.4 Regulatory Framework
    • 6.3.3.5 Disease Prevelance
  • 6.3.4 India
    • 6.3.4.1 Key country dynamics
    • 6.3.4.2 India polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.4.3 Market scenario
    • 6.3.4.4 Regulatory framework
    • 6.3.4.5 Disease prevelance
  • 6.3.5 Australia
    • 6.3.5.1 Key Country Dynamics
    • 6.3.5.2 Australia Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5.3 Market Scenario
    • 6.3.5.4 Regulatory Framework
    • 6.3.5.5 Disease Prevelance
  • 6.3.6 Thailand
    • 6.3.6.1 Key country dynamics
    • 6.3.6.2 Thailand polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.6.3 Market Scenario
    • 6.3.6.4 Regulatory Framework
    • 6.3.6.5 Disease Prevelance
  • 6.3.7 South Korea
    • 6.3.7.1 Key Country Dynamics
    • 6.3.7.2 South Korea Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7.3 Market scenario
    • 6.3.7.4 Regulatory framework
    • 6.3.7.5 Disease prevelance
• 6.4 Latin America
  • 6.4.1 Latin America Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2 Brazil
    • 6.4.2.1 Key country dynamics
    • 6.4.2.2 Brazil polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2.3 Market scenario
    • 6.4.2.4 Regulatory framework
    • 6.4.2.5 Disease prevelance
  • 6.4.3 Mexico
    • 6.4.3.1 Key Country Dynamics
    • 6.4.3.2 Mexico Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3.3 Market Scenario
    • 6.4.3.4 Regulatory Framework
    • 6.4.3.5 Disease Prevelance
  • 6.4.4 Argentina
    • 6.4.4.1 Key country dynamics
    • 6.4.4.2 Argentina polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4.3 Market scenario
    • 6.4.4.4 Regulatory framework
    • 6.4.4.5 Disease prevelance
• 6.5 MEA
  • 6.5.1 MEA Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2 South Africa
    • 6.5.2.1 Key Country Dynamics
    • 6.5.2.2 South Africa Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2.3 Market Scenario
    • 6.5.2.4 Regulatory Framework
    • 6.5.2.5 Disease Prevelance
  • 6.5.3 Saudi Arabia
    • 6.5.3.1 Key country dynamics
    • 6.5.3.2 Saudi Arabia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3.3 Market scenario
    • 6.5.3.4 Regulatory framework
    • 6.5.3.5 Disease prevelance
  • 6.5.4 UAE
    • 6.5.4.1 Key country dynamics
    • 6.5.4.2 UAE polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4.3 Market scenario
    • 6.5.4.4 Regulatory framework
    • 6.5.4.5 Disease prevelance
  • 6.5.5 Kuwait
    • 6.5.5.1 Key country dynamics
    • 6.5.5.2 Kuwait polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5.3 Market scenario
    • 6.5.5.4 Regulatory framework
    • 6.5.5.5 Disease prevelance

Chapter 7 Competitive Landscape

• 7.1 Participant's Overview
  • 7.1.1 MEDTRONIC
    • 7.1.1.1 Overview
    • 7.1.1.2 Financial Performance
    • 7.1.1.3 Product Benchmarking
    • 7.1.1.4 Strategic Initiatives
  • 7.1.2 STRYKER CORPORATION
    • 7.1.2.1 Overview
    • 7.1.2.2 Financial Performance
    • 7.1.2.3 Product Benchmarking
    • 7.1.2.4 Strategic Initiatives
  • 7.1.3 BASF SE
    • 7.1.3.1 Overview
    • 7.1.3.2 Financial Performance
    • 7.1.3.3 Product Benchmarking
    • 7.1.3.4 Strategic Initiatives
  • 7.1.4 EVONIK INDUSTRIES AG
    • 7.1.4.1 Overview
    • 7.1.4.2 Financial Performance
    • 7.1.4.3 Product Benchmarking
    • 7.1.4.4 Strategic Initiatives
  • 7.1.5 DSM
    • 7.1.5.1 Overview
    • 7.1.5.2 Financial Performance
    • 7.1.5.3 Product Benchmarking
    • 7.1.5.4 Strategic Initiatives
  • 7.1.6 BEZWADA BIOMEDICAL, LLC
    • 7.1.6.1 Overview
    • 7.1.6.2 Product Benchmarking
    • 7.1.6.3 Strategic Initiatives
  • 7.1.7 CORBION
    • 7.1.7.1 Overview
    • 7.1.7.2 Financial Performance
    • 7.1.7.3 Product Benchmarking
    • 7.1.7.4 Strategic Initiatives
  • 7.1.8 VICTREX PLC (INVIBIO LTD.)
    • 7.1.8.1 Overview
    • 7.1.8.2 Financial Performance
    • 7.1.8.3 Product Benchmarking
    • 7.1.8.4 Strategic Initiatives
  • 7.1.9 INTERNATIONAL POLYMER ENGINEERING
    • 7.1.9.1 Overview
    • 7.1.9.2 Product Benchmarking
    • 7.1.9.3 Strategic Initiatives
  • 7.1.10 COVALON TECHNOLOGIES LTD.
    • 7.1.10.1 Overview
    • 7.1.10.2 Financial Performance
    • 7.1.10.3 Product Benchmarking
    • 7.1.10.4 Strategic Initiatives
  • 7.1.11 ABBOTT
    • 7.1.11.1 Overview
    • 7.1.11.2 Financial Performance
    • 7.1.11.3 Product Benchmarking
    • 7.1.11.4 Strategic Initiatives
  • 7.1.12 ELIXIR MEDICAL
    • 7.1.12.1 Overview
    • 7.1.12.2 Product Benchmarking
    • 7.1.12.3 Strategic Initiatives
  • 7.1.13 REVA MEDICAL, LLC
    • 7.1.13.1 Overview
    • 7.1.13.2 Product Benchmarking
    • 7.1.13.3 Strategic Initiatives
  • 7.1.14 MERIL LIFE SCIENCES PVT. LTD.
    • 7.1.14.1 Overview
    • 7.1.14.2 Product Benchmarking
    • 7.1.14.3 Strategic Initiatives
  • 7.1.15 MICROPORT SCIENTIFIC CORPORATION
    • 7.1.15.1 Overview
    • 7.1.15.2 Financial Performance
    • 7.1.15.3 Product Benchmarking
    • 7.1.15.4 Strategic Initiatives
• 7.2 Participant Categorization
  • 7.2.1 Polymeric Biomaterials Market Share Analysis, 2023
• 7.3 Strategy Mapping
  • 7.3.1 Expansion
  • 7.3.2 Acquisition
  • 7.3.3 Collaborations & Partnerships
  • 7.3.4 Product Launch
  • 7.3.5 Others

Chapter 8 Analyst View